about
Spatiotemporal Regulation of Hsp90-Ligand Complex Leads to Immune ActivationMolecular Mechanism for p202-Mediated Specific Inhibition of AIM2 Inflammasome ActivationEmerging therapies for systemic lupus erythematosus--focus on targeting interferon-alphaThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityTLR ligands up-regulate Trex1 expression in murine conventional dendritic cells through type I Interferon and NF-κB-dependent signaling pathwaysThe pathogenesis, diagnosis and treatment of lupus nephritis.A meta-analysis of public microarray data identifies gene regulatory pathways deregulated in peripheral blood mononuclear cells from individuals with Systemic Lupus Erythematosus compared to those withoutMicrobiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study.Advances in systems biology approaches for autoimmune diseasesThe role of dendritic cells in tissue-specific autoimmunity.IL-4 suppresses the responses to TLR7 and TLR9 stimulation and increases the permissiveness to retroviral infection of murine conventional dendritic cells.Meta-analysis of two Chinese populations identifies an autoimmune disease risk allele in 22q11.21 as associated with systemic lupus erythematosus.Interferons in autoimmune and inflammatory diseases: regulation and roles.Amyloid-DNA Composites of Bacterial Biofilms Stimulate AutoimmunityToll-like receptors: potential targets for lupus treatmentMyeloid dendritic cells from B6.NZM Sle1/Sle2/Sle3 lupus-prone mice express an IFN signature that precedes disease onsetImmune-Mediated Nephropathy and Systemic Autoimmunity in Mice Does Not Require Receptor Interacting Protein Kinase 3 (RIPK3).Progesterone and autoimmune disease.The genetics of lupus: a functional perspective.B-cell selection and the development of autoantibodies.Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupusSTAT2 Is Required for TLR-Induced Murine Dendritic Cell Activation and Cross-PresentationGenome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients.Alterations in nuclear structure promote lupus autoimmunity in a mouse model.Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosusImmunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.Apoptosis and NET formation in the pathogenesis of SLE.Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases.The Regulation of Immune Responses by DC Derived Type I IFN.Modulation of autoimmune rheumatic diseases by oestrogen and progesterone.Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.Biologic therapies in systemic lupus erythematosus.Lupus nephritis: an update.TSG-6 Downregulates IFN-Alpha and TNF-Alpha Expression by Suppressing IRF7 Phosphorylation in Human Plasmacytoid Dendritic Cells.Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis.Targeting the interferon pathway with sifalimumab for the treatment of systemic lupus erythematosus.Analysis of microRNAs in patients with systemic lupus erythematosus, using Solexa deep sequencing.Interferon-targeted therapy in systemic lupus erythematosus: Is this an alternative to targeting B and T cells?A Lymphotoxin/Type I IFN Axis Programs CD8+ T Cells To Infiltrate a Self-Tissue and Propagate Immunopathology.Long-term Effects of Intravenous Cyclophosphamide in Combination with Mesna Provided Intravenously and via Bladder Perfusion in a Patient with Severe Multifocal Motor Neuropathy.
P2860
Q26744078-128EA490-271F-416D-AA0B-A2276B1766CEQ27679064-88BE5B36-0BDA-4979-89EA-E864627E141FQ28265144-3A6E5E2E-A2BB-491E-A507-ADECCEB68015Q28384138-1DAE98EB-CCB7-42D3-8C44-B93B524AF8B6Q28510527-B7DBF782-496D-461A-AC33-1C503518481BQ30596968-86546D31-8594-451D-A490-E90B6F772A68Q31142463-9C981348-CE5C-4701-BCDB-E565F23FD319Q33443585-F148E25F-56BF-4926-BEE5-BFBDA666EDFAQ33619013-787BF557-46DC-4692-A0C3-FEC8E0CF711AQ34422017-E531396C-7677-4769-A566-AF498D689419Q35086719-B75EC555-9351-4BE0-949C-67599DF8F5E9Q35499383-63946F9B-5244-40CA-8006-704FA834CCE4Q35603598-6F82836C-F0B3-4D70-BF66-79E4A275C6BEQ35845485-81F01FC0-6FA6-46A8-81F2-0EA895CDB4FBQ35848152-E254FC08-D661-4744-AAC2-BA92F78ADDBBQ36054583-49EB9B0E-9F64-4895-B2B0-221BE10A19D5Q36145022-4EB1FA9E-3F4F-4BE2-AD47-15B44E23B5F6Q36202227-E3E64282-6BB1-45F6-B879-2A84956E2FA1Q36245989-CA7766FB-9554-4CCD-9855-7728EEE39E9FQ36504635-3B290CD7-B4A9-4E5B-BD1D-E94E9344C894Q36966870-4BD52587-376F-4080-85A6-F1EF97DC04F7Q37018580-5510A2C6-C622-475D-9336-5BED48221806Q37215593-583FD955-482F-48C5-9150-D6F1C3FAB929Q37224632-DE1BAABB-4962-414B-A800-FECDB885538BQ37639733-608EEB4A-43CE-48DE-8B21-D4668FD0E4ECQ37979862-80F44784-00A1-4F77-9ADA-59B64ED2C70DQ38036709-E971E472-17FE-4A24-98F4-9F4376FCF430Q38068181-8D705F38-2D58-4CAC-8C33-74BCFCAE2E00Q38102693-409D91EB-AEED-44EC-9099-1436E39794FDQ38243118-7285E785-4928-4E5F-A9D6-156B348755BDQ38396871-31ACF7E7-DF92-4253-91CC-6C29D1FC5367Q38425831-3078F335-6A6E-4CA9-BBF3-86BF8F3FC51AQ38608138-A89CBBE2-BC1F-457F-9720-3436E34EA791Q38709337-E9394555-4749-49EF-B648-413461968D60Q38806359-A977E578-FB11-48A4-BE2F-43552BF66C00Q39045512-B9DBE85F-B2C4-4E2D-9CE3-176604F76E49Q39227873-83DC3C34-3231-43A4-BF49-D9FB04F327ADQ39517523-B6590291-E3C1-47FC-AABF-95C8AB67A6B1Q40440208-CB7CDD39-DCB1-48D5-B845-B6CE3C0CCA17Q41308052-92CA875E-1BFA-4850-AA93-ADF57E8BEE59
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Type I interferon and systemic lupus erythematosus.
@ast
Type I interferon and systemic lupus erythematosus.
@en
type
label
Type I interferon and systemic lupus erythematosus.
@ast
Type I interferon and systemic lupus erythematosus.
@en
prefLabel
Type I interferon and systemic lupus erythematosus.
@ast
Type I interferon and systemic lupus erythematosus.
@en
P2860
P356
P1476
Type I interferon and systemic lupus erythematosus.
@en
P2093
Keith B Elkon
Vivian V Stone
P2860
P304
P356
10.1089/JIR.2011.0045
P577
2011-08-22T00:00:00Z